US2019381124A1PendingUtilityA1
Compositions and methods for the treatment of orthopedic ailments
Est. expirySep 29, 2036(~10.2 yrs left)· nominal 20-yr term from priority
A61K 36/9068A61K 36/906A61K 31/198A61K 36/77A61P 19/10A61K 36/185
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A composition for enhancing treatment of orthopedic ailments stimulates iNOS and enhances treatment of orthopedic ailments when a pharmaceutically effective amount is administered over a sufficient period of time. The composition comprises ginger, Muira puama, Paullinia cupana, and at least one of the group consisting of L-arginine and L-citrulline.
Claims
exact text as granted — not AI-modified1 . A composition for enhancing treatment of orthopedic ailments, wherein administration of a pharmaceutically effective amount of the composition over a sufficient period of time stimulates iNOS and enhances treatment of orthopedic ailments, comprising:
ginger or a ginger derivative; Muira puama; Paullinia cupana ; and at least one of the group consisting of L-arginine and L-citrulline.
2 . (canceled)
3 . The composition according to claim 1 , wherein the composition comprises 250 mg to 2 g the ginger or ginger derivative.
4 . The composition according to claim 1 , including 10 mg to 3 g of L-arginine, L-citrulline, or a mixture of L-arginine and L-citrulline.
5 . The composition according to claim 1 , including 10 mg to 2 g of L-arginine, L-citrulline, or a mixture of L-arginine and L-citrulline
6 . The composition according to claim 1 , including 100 mg to 3 g of Muira puama.
7 . The composition according to claim 1 , including 500 mg to 1.5 g of Muira puama.
8 . The composition according to claim 1 , including at least 250 mg of Paullinia cupana.
9 . The composition according to claim 1 , including 500 mg of Paullinia cupana.
10 . The composition according to claim 1 , including 250 mg to 2 g of ginger or ginger derivative, 250 mg to 2 g of L-arginine, L-citrulline, or mixture of L-arginine and L-citrulline, 500 mg to 1.5 g of Muira puama , and 500 mg of Paullinia cupana.
11 . The composition according to claim 1 , wherein administration of the pharmaceutically effective amount of the composition over the sufficient period of time increases the rate of bone fracture healing.
12 . The composition according to claim 1 , wherein administration of the pharmaceutically effective amount of the composition over the sufficient period of time is effective in treatment of osteoporosis.
13 - 24 . (canceled)Join the waitlist — get patent alerts
Track US2019381124A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.